6 мар. 2024 г. · Paradigm uses OpenAI's API to improve patient access to clinical trials.

Augmenting clinical trial development with GPTs. One of the many solutions Moderna has built and is continuing to develop and validate with ChatGPT Enterprise ...

By providing access to powerful AI tools and resources, Open AI can help accelerate drug discovery, improve clinical trials, and enhance patient care.

13 нояб. 2024 г. · Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to improve drug development by speeding up clinical trial recruitment.

13 мар. 2024 г. · Scientists are starting to use AI to manage clinical trials, including the tasks of writing protocols, recruiting patients and analysing data.

Risk-based monitoring (RBM) is a clinical trial monitoring approach that focuses on identifying and managing the risks associated.

14 нояб. 2024 г. · Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to improve drug development by speeding up clinical ...

Genmab recently launched an innovative project to transform the creation of clinical trial documents, including clinical study reports (CSRs), patient safety ...

We worked with OpenAI and evaluated GPT-4 as a tool to reduce the administrative burden of screening patients for clinical trials.

12 нояб. 2024 г. · Sanofi and Formation Bio both plan to use Muse in their own clinical trials, including upcoming Phase 3 multiple sclerosis studies run by Sanofi ...